Focus: Expedited pathways - How expedited pathways benefit patients and the industry
Focus articles: Expedited pathways
- Conditional oncology drug approvals: A sponsor's perspective on the evolving landscape of FDA accelerated approvals
- New regulatory tools for drug developers: Sharing experience
- Time is running out for rare pediatric disease designation and priority review voucher programs
- A scientific approach to regulatory starting material selection
- Building best regulatory practices in Brazil
- The EMA’s Veterinary Big Data Stakeholder Forum (Part 2)
Use the issue archive below to download the complete issue as a PDF or to access individual articles or complete issues going back to 2015.
Note: To access members-only content, you must be logged in to the site with your TOPRA Member account.